MedPath

FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial

Not Applicable
Recruiting
Conditions
Critical Limb-Threatening Ischemia
Peripheral Arterial Occlusive Disease
Femoropopliteal Artery Occlusion
Claudication, Intermittent
Femoropopliteal Stenosis
Registration Number
NCT06082466
Lead Sponsor
Paracelsus Medical University
Brief Summary

The purpose of this clinical trial is to analyze patency after autologous infrainguinal bypass surgery in patients receiving a venous conduit versus a covered venous conduit.

Detailed Description

Patients presenting to Vascular Surgical Units are usually multimorbid with increased cardiopulmonary risk. Autologous venous bypass is indicated in certain situations despite the longer duration of surgery. Optimizing patency has been an important goal since many years. Reconstruction problems are often based on intimal hyperplasia, which can be reduced via covering of the harvested vein as seen in previous studies.

This clinical trial will be conducted at our Division of Vascular Surgery and Endovascular Surgery at the University Hospital of Salzburg. Patients will be randomized into one of the two treatment options, which are a plain venous conduit or a by mesh covered venous conduit. During this clinical trial, the first follow-up will take place after 6 weeks; this corresponds to the usual follow-up interval. Due to the trial, further follow-ups will take place for each of the patients after 3 months, 6 months, 12 months, 2 years.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of primary patency of the venous bypass2 years

The incidence of patency of the venous bypasses will be analysed and compared. This is defined as freedom from occlusion of the venous bypass.

Secondary Outcome Measures
NameTimeMethod
Incidence of limb salvage after procedure2 years

Amputation free survival

Incidence of procedure-related mortality2 years

Mortality intervention-related

Incidence of 30-day mortality30 days

Number of participants, who die within 30 days after the procedure.

Trial Locations

Locations (1)

University Hospital of Salzburg, Paracelsus Medical University

🇦🇹

Salzburg, Austria

University Hospital of Salzburg, Paracelsus Medical University
🇦🇹Salzburg, Austria
Klaus Linni, MD PD
Contact
k.linni@salk.at

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.